World Hepatitis Day
Every year on July 28th, World Hepatitis Day raises awareness on viral hepatitis. Hepatitis B (HBV) and Hepatitis C (HCV) are considered the most concerning viral hepatitis types.
Hepatitis B causes both acute and chronic infections. With the latter having the potential to cause liver cirrhosis, liver cancer, and other potentially fatal side effects.
Although HBV vaccinations have been quite effective, immunocompromised people such as HIV patients, elderly , smokers, patients with renal failure, and obese people may not develop protective antibodies.
Recent Hepatitis B vaccination studies have shown the potential of skin vaccination as a promising alternative to intramuscular injections. Indeed, studies have demonstrated the effectiveness of intradermal vaccination. Especially for non-responders populations, and its potential to augment the immune response.
On World Hepatitis Day, we’re sharing a very interesting White Paper on: all you need to know about HBV and the advances in its vaccination using the intradermal route and VAX-ID®.
Read the White Paper 📄 here 👉 “Recent advances in Hepatitis B skin vaccination and immunization.“
Want to read more? Check out the publication by Van Mulder et al on Hepatitis B vaccination using VAX-ID here.
Interested in our solutions?
Contact our commercial team!